Global Personalized Medicine Diagnostics Market - Forecasts to 2016
DUBLIN, February 5, 2014 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/3vvhng/global) has announced the addition of the "Global Personalized Medicine Diagnostics Market - Forecasts to 2016" report to their offering.
(Logo: http://photos.prnewswire.com/prnh/20130307/600769 )
One of the main trends witnessed in the Global Personalized Medicine Diagnostics market is the development of innovative tools and technologies. For instance, AssureRx Health Inc. launched GeneSightRx ADHD in May 2012, a personalized medicine test for the growing number of children and adults diagnosed with ADHD. Moreover, Bristol-Myers Squibb Co. collaborated with MMRF in December 2012 for advanced personalized medicine for multiple Myeloma. Further, Alacris Theranostics GmbH entered into an agreement with GlaxoSmithKline plc in November 2012 to use ModCell system for early stage cancer research. Furthermore, AltheaDx Inc. launched FLT3 Mutation Assay in October 2012. Agendia N.V. launched ColoPrint microarray-based 18-gene expression signature in June 2012 to predict the risk of distant recurrence for stage II colon cancer patients. The European Medicines Agency approved Zelboraf, manufactured by F. Hoffmann-La Roche Ltd., in December 2011.
According to the report, one of the main factors driving the market is the increasing demand for personalized medicine diagnostics for treatment of cancer. Hyperthermia is one of the treatments of cancer where the use of personalized medicines and diagnostics is considered depending on a patient's specific attributes. Methods of treatments such as hyperthermia and radiotherapy have already been proposed.
Further, the report states that one of the main challenges is low awareness about personalized medicine diagnostics in developing countries. Most of the patients in developing countries such as India and China are not fully aware of the recent developments in personalized medicine diagnostics. The high cost of personalized medicine diagnostics in certain treatments is another major challenge for the market in these countries.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Key Topics Covered:
1. Executive Summary
2. List of Abbreviations
3. Introduction
4. Market Research Methodology
5. Scope of the Report
6. Market Landscape
7. Key Market Segmentation
8. Geographical Segmentation
9. Key Leading Countries
10. Vendor Landscape
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Key Vendor Analysis
18. Other Reports in this Series
Companies Mentioned:
- 20/20 GeneSystems Inc.
- Abbott Laboratories
- Accumetrics Inc.
- AdvanDx Inc.
- Affymetrix Inc.
- Agilent Technologies Inc.
- Almac Group Ltd.
- AltheaDx Inc.
- Ambry Genetics Corp.
- Amgen Inc.
- Arrayit Corp.
- AssureRx Health Inc.
- Autogenomics Inc.
- BG Medicine Inc.
- Becton Dickinson and Company
- Bio-Reference Laboratories Inc.
- BioCurex Inc.
- Biocare Medical LLC
- Biocartis SA
- Biocept Inc.
- Biodesix Inc.
- CombiMatrix Corp.
- Corgenix Medical Corp.
- DxTerity Diagnostics Inc.
- EnzoBiochem Inc.
- Epigenomics AG
- Euroimmun AG
- GE Healthcare
- Genomic Health Inc.
- Illumina Inc.
- Interleukin Genetics Inc.
- Johnson & Johnson
- Knome Inc.
- Lab21 Ltd.
- Life Technologies Corp.
- MDxHealth SA
- Myriad Genetics Inc.
- Nanosphere Inc.
- Pathway Genomics Corp.
- Power3 Medical Products Inc.
- Quest Diagnostics Inc.
- Response Genetics Inc.
- Rosetta Genomics Ltd.
- Sequenom Inc.
- Trovagene Inc.
- Vermillion Inc.
- Viracor-IBT Laboratories Inc.
- and Roche Holding AG.
- bioMerieux SA
For more information visit http://www.researchandmarkets.com/research/3vvhng/global
Media Contact: Laura Wood , +353-1-481-1716, [email protected]
SOURCE Research and Markets
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article